BIOLOOMICS
BioLoomics is a preclinical stage biotechnology company that uses evolution in a microscope to develop drug discovery tools and protein drugs. Our VariVolve platform tests millions of protein designs for a targeted activity in hours, enabling efficient mining of the vast chemical space of protein designs. A strong advantage of our approach is the use of whole intact cells as test vessels that capture complex drug behavior not attainable in conventional assays.
BIOLOOMICS
Industry:
Biotechnology Health Care Sensor
Founded:
2019-01-01
Address:
Boulder, Colorado, United States
Country:
United States
Website Url:
http://www.bioloomics.com
Total Employee:
1+
Status:
Active
Total Funding:
1.42 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Wordpress Plugins Nginx Sitelinks Search Box
Similar Organizations
Revolution BioSciences
Revolution BioSciences is an early stage drug discovery company offering CRO bioanalytical services and consulting, and MALDI MS products.
Ranok Therapeutics
Ranok is a privately held, pre clinical stage bio company that is pioneering an innovative targeted protein degradation technology.
Neurolytixs
Neurolytixs is a biotechnology company that develops health care technology to aid biomarker discovery for the diagnosis of concussions.
Novir
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted partners delivering smart.
Nexus BioPharma
This company is a preclinical stage biotechnology company developing new therapies and intellectual property.
Nicoya Lifesciences
Nicoya is a nanotechnology company developing sensor products that will change the world
Vernal Biosciences
Vernal Biosciences specializes in high-purity mRNA for research and clinical use.
Viking Scientific
Viking Scientific is a preclinical stage drug delivery company that develops next-generation controlled release products.
Voronoi
Voronoi is a biotech company that develops novel kinase inhibitors and target protein degraders.
Vironika
Vironika is an early stage drug discovery company dedicated to developing novel drugs to block deadly tumor viruses from forming cancers.
MBX Biosciences
MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.
Mosaic Sensors
Mosaic Sensors focuses on commercializing a optical sensor technology for disease diagnosis, health monitoring & the cannabis industry.
May & Meadow
May & Meadow is developing digital health technologies to assist mothers and newborn infants dealing with feeding difficulties.
Metabiomics
Metabiomics is an early stage molecular diagnostics company that is developing in-vitro diagnostics.
Midori Renewables
Midori Renewables is a flagship VentureLabs company that deploys its innovative carbohydrate science technology platforms.
Multispan
Multispan is a biotechnology company engaged in drug discovery research focused on G protein-coupled receptors (GPCRs).
Lucentix
Lucentix develops a biosensor technology that enables patients to measure concentrations of analytes in a single drop of blood or saliva.
Lubris BioPharma
Lµbris BioPharma is a development-stage life science company producing and commercializing a version of the human protein, lubricin.
Livzon Mabpharm
Livzon Mabpharm is a Chinese biotechnology company focused on the development, manufacture, and sale of antibody-based drugs.
AQUA Biomaterials
AQUA Biomaterials, a biotech company, provides contract services such as technical advice, product prototyping, and process development.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Aeglea BioTherapeutics
Aeglea BioTherapeutics is a clinical-stage biotechnology company that develops enzyme therapies for rare metabolic diseases.
AUM LifeTech
AUM LifeTech is a Philadelphia based biotechnology company with a revolutionary nucleic acids platform.
ALX Oncology
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Attogene
Attogene is a biotechnology company that develops cutting-edge technologies for sensing compounds in a wide range of samples.
AniV8
AniV8 is a developer of clinical sensor technology to diagnose and monitor diseases affecting companion animals.
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Anagenex
Anagenex is a seed stage biotechnology company building a novel platform for drug discovery focusing on difficult targets.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Extend Biosciences
Extend Biosciences is an emerging biotechnology company developing a novel drug delivery platform technology.
EarlyCell
EarlyCell is a biotechnology company that develops genetic and expression diagnostics for unmet or poorly diagnosed conditions.
Bloom Science
Bloom Science is a platform Biotechnology company discovering and developing revolutionary new drugs.
Bioelectronica
Bioelectronica is a biotechnology company building next-generation digital tools for drug discovery, diagnostics and cell sorting.
FibrosIX
FibrosIX is a biotechnology company develops drugs to prevent lung fibrosis in cancer patients.
Fornia BioSolutions
Fornia BioSolutions is an innovative biotechnology company that specializes in developing microbial products.
Taurus Biosciences
Taurus Biosciences is a private biotechnology company that discovers and develops novel cow antibodies.
Truuscann
Truuscann is developed a first-to-market crossmorphic sensor.
Telis Bioscience
Telis Bioscience is a venture-backed biotechnology firm that develops protein therapeutics.
TPP Global Development
TPP Global Development is a preclinical stage drug development company focused on nervous system disorders, immunology, and oncology.
4D pharma Research Ltd
4D pharma Research Limited, a biotechnology company, develops drug compounds from gut bacteria for the prevention.
Qrons
Qrons is a publicly-traded, preclinical biotechnology company that develops advanced cell-based solutions to combat neurological injuries.
SenGenix
SenGenix develops point-of-care diagnostic tests that deliver accurate and actionable patient data.
SalubrisBio
SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.
Spawnfoam
Spawnfoam is a biotechnology company for the development of well-designed biomaterials.
Diversa Corporation
Diversa Corporation is an industrial biotechnology company that develops high performance enzymes.
HeMemics Biotechnologies
HeMemics Biotechnologies is a biotech company which develops rapid diagnostic test platforms.
Isosceles Pharmaceuticals
Isosceles Pharmaceuticals is a preclinical stage biotech company that is working on perioperative acute pain product candidates.
Onda Vision Technologies
Onda Vision Technologies is to develop a Safety-as-a-Service product to minimize unnecessary youth fatalities, reduce medical costs.
Ocean Biomedical
Ocean Biomedical is a biotechnology company that accelerates new discoveries in the world of medicine.
Orion Biotechnology
Orion Biotechnology is a clinical stage biotechnology company that develops novel medical treatments.
Zepteon
Zepteon is a privately held corporation that develops purification tools capable of separating antibodies with specific sugar structures.
CombinatoRx
CombinatoRx is a biotech company that develops medicines from synergistic combinations of approved drugs.
Carrera Bioscience
Carrera Bioscience is a biotechnology company that develops novel molecular diagnostics and biosensors.
Clarify Analytical
Clarify Analytical is an innovative start-up committed to develop and provide state-of-the-art Mass Spectrometry based methodologies.
ProteoThera
ProteoThera, Inc. is an early stage biotechnology company that is advancing drug targeting technology.
PamBio
PamBio is a pre-clinical stage biotechnology company developing drug therapy for acute bleeding conditions.
Yikai Zhineng
Yikai Zhineng is a company engaged in the development of home-care, smart care, and home-care pension service management platform.
Current Employees Featured
Jeremy Jacobsen Director of Bioinformatics and Automation @ BioLoomics
Director of Bioinformatics and Automation
2019-08-01
Doug Chapnick CEO and Founder @ BioLoomics
CEO and Founder
Founder
Official Site Inspections
http://www.bioloomics.com
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "BioLoomics"
Bioloomics
BioLoomics Closes $600k Pre-Seed Round to Launch Biosensing Drug Discovery Platform. We are excited to announce that on May 30, 2019, BioLoomics closed a $600,000 pre-seed …See details»
About Us - Bioloomics
After seven years of DARPA-funded research in the Rapid Threat Assessment (RTA) program at the University of Colorado, Boulder, a eureka moment led to the founding of BioLoomics. Co …See details»
Bioloomics
BioLoomics closed a $575,000 round of pre seed extension funding on May 11, 2021.. September 25, 2023. View News Article. OEDIT Grant Award. Nov 21, 2019. OEDIT Grant Award.See details»
BioLoomics - Crunchbase Company Profile & Funding
BioLoomics may be growing as it has successfully raised USD 8.7 million in seed financing, which is a strong indicator of investor confidence and capital availability for expansion and research. …See details»
BioLoomics - LinkedIn
BioLoomics is a preclinical stage biotechnology company leveraging directed evolution of antibodies in human cells to create ADCs with improved internalization and trafficking.See details»
BioLoomics Company Profile 2025: Valuation, Funding …
BioLoomics General Information Description. Developer of biosensor technology intended to accelerate drug discovery through the power of synthetic biology and live-cell imaging. The company's technology uses high-throughput …See details»
BioLoomics Company Profile | Management and Employees List
BioLoomics Profile and History . Bioloomics, Inc. provides a novel drug screening service to analyze drug action and toxicity. Working every day to radically improve drug discovery and …See details»
Bioloomics, Inc. Company Profile | Boulder, CO | Competitors ...
Find company research, competitor information, contact details & financial data for BioLoomics, Inc. of Boulder, CO. Get the latest business insights from Dun & Bradstreet.See details»
BioLoomics, Inc. Overview | SignalHire Company Profile
BioLoomics is a preclinical stage biotechnology company leveraging directed evolution of antibodies in human cells to create target degrading antibodies. Our proprietary tech combines …See details»
BioLoomics - Crunchbase
BioLoomics is a biotechnology company that develops antibodies for cancer therapies.See details»
BioLoomics Company Profile - Office Locations, Competitors
BioLoomics is a preclinical-stage biotechnology company leveraging the directed evolution of antibodies in human cells to create target-degrading antibodies. It incorporates synthetic …See details»
BioLoomics - Contacts, Employees, Board Members, Advisors
Organization. BioLoomics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. Number of Board …See details»
BioLoomics Company Profile: Overview and Full News Analysis
BioLoomics is composed of interdisciplinary pioneers with expertise in synthetic biology, machine learning, and protein design, all working towards creating the next generation of antibody …See details»
BioLoomics - Products, Competitors, Financials, Employees, …
Jun 13, 2019 About BioLoomics. BioLoomics is a biotechnology company focused on revolutionizing antibody-drug conjugates (ADCs) for safer cancer therapies. The company …See details»
BioLoomics - Overview, News & Similar companies | ZoomInfo.com
Sep 19, 2023 BioLoomics Raises $8.7 Million Seed Round to Develop Target Degrading Antibodies BOULDER, Colo.--(BUSINESS WIRE)--BioLoomics, the company pioneering …See details»
BioLoomics Raises $8.7 Million in Seed Funding to Develop Target ...
Sep 19, 2023 BioLoomics, a company specializing in the directed evolution of target-degrading antibodies using human cells, has secured $8.7 million in seed financing to advance its …See details»
BioLoomics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
BioLoomics - Webflow
BioLoomics is a synthetic biology company operating at the cutting edge of drug discovery. In scaling their business, BioLoomics approached Wunderdogs to bring clarity and focus to their …See details»
Our Technology - Bioloomics
We utilize AI-driven spatial and kinetic parameters to identify the ideal antibody from a vast array of options, streamlining our search process.See details»
BiomiX, a user-friendly bioinformatic tool for democratized …
2 days ago The arise of high-throughput technologies has enabled the generation of vast amounts of data on multiple levels of biological organization, as observed in the autoimmunity …See details»